Is Nicotinamide and Niacinamide the Same?

Nicotinamide and niacinamide are the same compound, full stop. They share the same molecular structure, the same biological activity, and the same entry in chemical databases. The two names exist because medicine and the cosmetics industry settled on different conventions: pharmaceutical and research literature tends to use “nicotinamide,” while skincare brands and the cosmetics industry overwhelmingly prefer “niacinamide.”¹ The real confusion worth untangling is not between these two names but between this compound and its chemical cousin, niacin, which behaves quite differently in the body.

Why Two Names for One Molecule

Both “nicotinamide” and “niacinamide” refer to the amide form of vitamin B3. In scientific journals, clinical trials, and pharmacology textbooks, the preferred name is nicotinamide. In the cosmetics industry, regulatory filings, and most product labels you see at a drugstore, the same molecule goes by niacinamide. Neither name is more “correct” than the other. If you pick up a serum labeled “niacinamide 10%” and a supplement labeled “nicotinamide 500 mg,” the active ingredient is identical.²

The dual-naming situation partly traces back to the history of vitamin B3 itself. When the vitamin was first isolated, the term “nicotinic acid” was used because of the molecule’s structural relationship to nicotine, though the two have nothing in common pharmacologically. The food industry worried that consumers would think their bread contained tobacco, so “niacin” was introduced as a friendlier label for nicotinic acid. The amide form followed a similar path: “nicotinamide” is the systematic chemistry name, and “niacinamide” became the consumer-facing synonym. You can find both names on government nutrient databases, and they refer to the same thing.

The Distinction That Actually Matters: Nicotinamide vs. Niacin

Where people genuinely get tripped up is the difference between nicotinamide (niacinamide) and niacin (nicotinic acid). These are both forms of vitamin B3, and the body can convert niacin into nicotinamide. But they are not interchangeable, especially at higher doses, because they do different things once you move beyond basic nutritional needs.

Niacin, in pharmacological doses, has been used for decades to manage cholesterol. It was one of the earliest drugs shown to lower serum cholesterol in humans, and a long line of research has documented its ability to shift lipid profiles favorably.³ Nicotinamide does not share this lipid-lowering property. If your doctor prescribes niacin for cholesterol, swapping in a niacinamide supplement will not have the same effect.

The flip side is that niacin produces one of the most notorious side effects in all of vitamin therapy: flushing. Within minutes of taking a dose, many people experience intense redness, warmth, and itching of the skin, particularly on the face and upper body. This happens because niacin activates a receptor on immune cells in the skin, triggering a cascade that dilates blood capillaries near the surface.⁴ Nicotinamide does not activate this pathway, so flushing is essentially absent when you take it instead. That single difference is a major reason why nicotinamide is the form used in skincare products and in many supplement contexts where flushing would be unacceptable.

How Your Body Handles Nicotinamide

Nicotinamide is a precursor to nicotinamide adenine dinucleotide, commonly known as NAD+. This molecule sits at the center of hundreds of metabolic reactions, including those involved in energy production, DNA repair, and cell signaling. When you take nicotinamide, orally or topically, it feeds into the production of NAD+, and that is the mechanism behind most of its studied health benefits.

You also make some nicotinamide internally. The amino acid tryptophan, found in protein-rich foods, can be converted to nicotinamide in the liver. The conversion is not especially efficient: human studies indicate that roughly 67 mg of dietary tryptophan yields about 1 mg of nicotinamide.⁵ That ratio means you would need a very tryptophan-heavy diet to meet your B3 needs through this pathway alone. Most people get the bulk of their vitamin B3 from foods like poultry, fish, legumes, and fortified grains, where it is present in directly usable forms. The marketplace offers nicotinamide (niacinamide) as a standalone supplement that is readily bioavailable, along with various forms of niacin including extended-release versions and inositol hexanicotinate.

Why Niacinamide Dominates the Skincare Aisle

If you have spent any time browsing serums and moisturizers in the last several years, you have probably noticed niacinamide near the top of ingredient lists. Its popularity is not just marketing hype; there is a reasonable stack of evidence behind it, touching on skin barrier function, pigmentation, and inflammation.

On the barrier side, topical nicotinamide has been shown to boost production of ceramides and free fatty acids in the outer layer of the skin, which translates to less water loss and better hydration in people with dry skin.⁶ Ceramides are the lipids that hold skin cells together like mortar between bricks, and when they are depleted, the skin feels tight and flaky. Nicotinamide appears to nudge the skin into making more of its own structural lipids rather than simply coating the surface.

For uneven skin tone, niacinamide takes an interesting approach. It does not inhibit melanin production itself. Instead, it interferes with the transfer of melanin-containing packets from the cells that produce pigment to the surrounding skin cells. In lab models, this transfer was reduced by roughly 35 to 68 percent.⁷ That mechanism is different from ingredients like hydroquinone or vitamin C, which target the pigment-making process earlier in the chain. The practical result for most users is a gradual evening of skin tone and fading of dark spots over weeks to months of consistent use.

Nicotinamide also has anti-inflammatory properties relevant to acne-prone skin. Acne bacteria trigger skin cells to pump out inflammatory signals, and nicotinamide dials down that response in a dose-dependent way, reducing the production of a key inflammatory molecule called IL-8.⁸ This is one reason dermatologists sometimes recommend niacinamide-containing products alongside other acne treatments. It tends to be gentler than many prescription actives, and because it is not an acid or a retinoid, it layers well with other ingredients without increasing irritation.

Skin Cancer Prevention

One of the more striking findings in nicotinamide research comes from oncology, specifically the prevention of nonmelanoma skin cancers in high-risk individuals. A large phase 3 trial published in the New England Journal of Medicine tested oral nicotinamide (500 mg twice daily) against placebo in people who had already had at least two nonmelanoma skin cancers in the previous five years. At 12 months, the nicotinamide group had roughly 23 percent fewer new nonmelanoma skin cancers compared to the placebo group. When broken down by type, squamous cell carcinomas were reduced by about 30 percent and basal cell carcinomas by about 20 percent, though the basal cell result did not quite reach statistical significance.⁹

The proposed explanation ties back to NAD+ and DNA repair. Ultraviolet radiation damages DNA in skin cells, and repairing that damage requires energy in the form of NAD+. By supplying extra nicotinamide, you give the cellular repair machinery more fuel to work with. This is a preventive strategy, not a treatment for existing cancers, and the protective effect disappeared once participants stopped taking nicotinamide. The trial population was specifically people at very high risk, so these results should not be read as a blanket recommendation for everyone to start megadosing, but the findings were notable enough that some dermatologists now suggest nicotinamide supplementation for patients with a strong history of sun-related skin cancers.

Neuroprotective Research

Beyond the skin, nicotinamide has drawn attention in neuroscience. Its role as a NAD+ precursor makes it relevant to brain cells, which have exceptionally high energy demands and are especially vulnerable to oxidative damage. Reviews of the literature have linked nicotinamide to neuroprotective effects in the context of traumatic brain injury, stroke, and several neurodegenerative diseases including Alzheimer’s, Parkinson’s, and Huntington’s.¹⁰

Much of this work is preclinical, meaning it has been done in animal models or cell cultures rather than large human trials. In a mouse model of Parkinson’s disease, nicotinamide treatment reversed several hallmarks of the disease: it reduced the abnormal buildup of a protein called alpha-synuclein, restored markers of dopamine-producing neurons, and improved motor function. It also reduced oxidative stress and neuroinflammation through multiple signaling pathways.¹¹ Separate experiments in human neuroblastoma cells and fruit fly models showed that high-dose nicotinamide protected against mitochondrial damage and improved motor deficits.¹²

The gap between promising preclinical data and proven clinical benefit is wide, and the neuroscience field is littered with compounds that looked great in mice and went nowhere in humans. Still, nicotinamide’s established safety profile at moderate doses and its fundamental role in cellular energy metabolism keep it on the radar of researchers studying neurodegeneration. One mechanism that keeps appearing in this research involves the enzyme sirtuin 1 (SIRT1), which nicotinamide can inhibit. Sirtuins use NAD+ as a cofactor and are involved in regulating inflammation, stress responses, and gene expression in neurons.¹³ Whether manipulating sirtuin activity through nicotinamide would be beneficial in human neurodegenerative disease remains an open question.

The Type 1 Diabetes Trials That Fell Short

One area where nicotinamide generated enormous hope but ultimately failed to deliver is the prevention of type 1 diabetes. The logic was appealing: type 1 diabetes is driven by autoimmune destruction of insulin-producing beta cells in the pancreas, and nicotinamide had shown protective effects on those cells in laboratory studies. If you could catch people early, during the phase when their immune system was attacking beta cells but before full-blown diabetes developed, perhaps nicotinamide could slow or prevent the damage.

Two major controlled trials tested this hypothesis. The Deutsche Nicotinamide Intervention Study enrolled high-risk individuals, including relatives of people with type 1 diabetes who had tested positive for certain antibodies. After up to 3.8 years of follow-up, the diabetes rates were similar in both the nicotinamide and placebo groups, and the trial was stopped early because there was essentially no signal of benefit.¹⁴

The European Nicotinamide Diabetes Intervention Trial (ENDIT) was even larger, and its conclusions were equally discouraging. Of the 159 participants who developed diabetes during the trial, 82 were taking nicotinamide and 77 were on placebo. The adjusted hazard ratio was essentially 1.0, meaning the treatment made no detectable difference whatsoever.¹⁵ These were well-designed, large-scale trials, and their failure was definitive enough to effectively close this chapter of nicotinamide research. It is a useful reminder that preclinical promise does not always translate, even with a compound as well-studied as nicotinamide.

Safety at a Glance

Nicotinamide has a favorable safety profile compared to many supplements. In the cosmetics industry, it has been used as a hair and skin conditioning agent for years and has undergone formal safety assessment.¹ Oral doses of up to 1,000 mg per day, the amount used in the skin cancer prevention trial, were well tolerated in that study’s population. At very high doses, some people report mild gastrointestinal upset or headache. Unlike niacin, nicotinamide does not cause the uncomfortable flushing reaction even at substantial doses, which is one of the practical reasons it is the preferred B3 form for both supplements and topical products.

Where some caution is warranted is with megadosing beyond what has been studied in controlled settings. Nicotinamide inhibits sirtuins and interacts with NAD+ metabolism in complex ways, and the long-term effects of very high doses are not fully mapped. For most people using a topical niacinamide serum at concentrations between 2 and 5 percent, or taking an oral supplement in the range a doctor recommends, the risk of problems is low. If you are considering high-dose supplementation for a specific medical purpose, that is a conversation to have with your doctor, since the appropriate dose depends on the condition being targeted.

Reading Product Labels Without Getting Confused

Knowing that nicotinamide and niacinamide are the same compound simplifies a lot of label-reading, but the broader vitamin B3 family can still trip people up. Here is what you are likely to encounter:

Niacinamide: The name you will see on most skincare serums, moisturizers, and some dietary supplements. This is the amide form of vitamin B3.
Nicotinamide: The same molecule, typically seen in medical literature, clinical trial reports, and pharmaceutical-grade supplements.
Niacin: Nicotinic acid, the other major form of vitamin B3. Used medically for cholesterol management. Causes flushing. Not interchangeable with niacinamide for skincare or cancer prevention purposes.
Nicotinamide riboside (NR): A newer NAD+ precursor supplement that has gained popularity in the longevity space. It is a different compound from nicotinamide, though both ultimately feed into NAD+ production.
Inositol hexanicotinate: Sometimes marketed as “flush-free niacin,” this is six niacin molecules bound to inositol. Its effectiveness and bioavailability differ from both plain niacin and nicotinamide.

When a skincare product advertises “vitamin B3” without specifying which form, it almost always means niacinamide. Niacin would be an unusual and poorly tolerated choice for topical application given its flushing properties. If you are shopping for supplements and your goal is the skin-related or neuroprotective benefits discussed in research, look for nicotinamide or niacinamide on the label. If your goal is cholesterol management, you need niacin specifically, and under medical supervision, because the dosing and monitoring requirements are different.

Concentration matters in topical products. Most research on niacinamide’s skin benefits has used concentrations between 2 and 5 percent. Some consumer products go as high as 10 or even 20 percent, and at those levels, some people experience redness or irritation, which is ironic for an ingredient valued partly for its anti-inflammatory properties. Starting at a lower concentration and working up is a sensible approach, especially if your skin tends to be reactive.